In summary, this is the first report of human testis-specific enhancers that, if duplicated or deleted lead to 46,XX or 46,XY DSD (sex reversal), respectively, with no effect on other developmental processes that require SOX9 (i.e absence of skeletal abnormalities or other features of campomelic dysplasia). This evidence concerns the gene SOX9 and disorder of sexual differentiation.